Free Trial
OTCMKTS:PVCT

Provectus Biopharmaceuticals (PVCT) Stock Price, News & Analysis

Provectus Biopharmaceuticals logo
$0.08 0.00 (-3.46%)
As of 10/17/2025 03:58 PM Eastern

About Provectus Biopharmaceuticals Stock (OTCMKTS:PVCT)

Advanced

Key Stats

Today's Range
$0.07
$0.08
50-Day Range
$0.06
$0.09
52-Week Range
$0.06
$0.15
Volume
175,500 shs
Average Volume
215,428 shs
Market Capitalization
$31.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PVCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PVCT Stock News Headlines

Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
See More Headlines

PVCT Stock Analysis - Frequently Asked Questions

Provectus Biopharmaceuticals' stock was trading at $0.1201 at the beginning of 2025. Since then, PVCT shares have decreased by 37.3% and is now trading at $0.0753.

Shares of PVCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Provectus Biopharmaceuticals investors own include Vertex Energy (VTNR), Good Times Restaurants (GTIM), Merck & Co., Inc. (MRK), Oncolytics Biotech (ONC), American Superconductor (AMSC), Cannabis Science (CBIS) and (DARA) (DARA).

Company Calendar

Today
10/18/2025
Next Earnings (Estimated)
11/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PVCT
Previous Symbol
NYSEMKT:PVCT
CIK
315545
Employees
4
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.76 million
Net Margins
-1,374.19%
Pretax Margin
-1,393.71%
Return on Equity
N/A
Return on Assets
-792.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.09
Quick Ratio
0.09

Sales & Book Value

Annual Sales
$620 thousand
Price / Sales
51.04
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-7.53

Miscellaneous

Outstanding Shares
420,280,000
Free Float
358,499,000
Market Cap
$31.65 million
Optionable
Not Optionable
Beta
0.58

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:PVCT) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners